Clinical trial
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
NCT00176436 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00176436 |
|---|---|
| Title | Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients |
| Official title | Double-Blind Study of Atomoxetine for Weight Management in Patients Taking Olanzapine or Clozapine |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Behavioral |
| Interventions | Diet support group, Group counseling and exercise |
| Enrollment | 40 |
| Start date | Feb 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 14, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: